EGF and neoplasm: Of note, Spry was shown to be an important negative regulator of protumorigenic fibroblast growth factor (FGF) and epidermal growth factor (EGF) signaling pathways (9, 12), underscoring the importance of this molecule and the newly identified mechanism in tumor suppression.